Eastling Thomas Wilson

Gyre Therapeutics, Inc. · Chief Financial Officer

Eastling Thomas Wilson is listed in public filings as officer: Chief Financial Officer. This Eastling Thomas Wilson insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Gyre Therapeutics, Inc. (GYRE). Investors use Eastling Thomas Wilson's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Gyre Therapeutics, Inc.GYRE$554k92.7k sharesGrant / ExerciseMay 4, 2026$554.2K92.7k shares$5.98--
Gyre Therapeutics, Inc.GYRE$222k95.1k sharesGrant / ExerciseMay 4, 2026$222.4K95.1k shares$2.34--
Gyre Therapeutics, Inc.GYRE$67k33.3k sharesGrant / ExerciseMay 4, 2026$66.5K33.3k shares$2.00--
Gyre Therapeutics, Inc.GYRE$44k47.5k sharesGrant / ExerciseMay 4, 2026$44.2K47.5k shares$0.93--
Gyre Therapeutics, Inc.GYRE$30k95.1k sharesGrant / ExerciseMay 4, 2026$30.4K95.1k shares$0.32--
Gyre Therapeutics, Inc.GYRE$24k11.9k sharesGrant / ExerciseMay 4, 2026$23.8K11.9k shares$2.00--
Gyre Therapeutics, Inc.GYRE$11k33.3k sharesGrant / ExerciseMay 4, 2026$10.6K33.3k shares$0.32--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Gyre Therapeutics, Inc.GYRE$223k26k sharesGrant / ExerciseJun 4, 2025$223.1K26k shares$8.58--
Gyre Therapeutics, Inc.GYRE$104k15k sharesGrant / ExerciseApr 16, 2025$104.0K15k shares$6.93--
Gyre Therapeutics, Inc.GYRE$259k26k sharesGrant / ExerciseAug 14, 2024$259.5K26k shares$9.98--